Literature DB >> 8220901

Nitric oxide-dependent and -independent hyperaemia due to calcitonin gene-related peptide in the rat stomach.

P Holzer1, I T Lippe, M Jocic, C Wachter, R Erb, A Heinemann.   

Abstract

1. Calcitonin gene-related peptide (CGRP) potently enhances mucosal blood flow in the rat stomach. The aim of this study was to examine whether CGRP also dilates extramural arteries supplying the stomach and whether the vasodilator action of CGRP involves nitric oxide (NO). 2. Rat CGRP-alpha (0.03-1 nmol kg-1, i.v.) produced a dose-dependent increase in blood flow through the left gastric artery (LGA) as determined by an ultrasonic transit time technique in urethane-anaesthetized rats. Blockade of NO synthesis by NG-nitro-L-arginine methyl ester (L-NAME, 20 and 60 mumol kg-1, i.v.) significantly reduced basal blood flow (BF) in the LGA and attenuated the hyperaemic activity of CGRP by a factor of 2.8-4. D-NAME tended to enhance basal BF in the LGA but had no influence on the dilator activity of CGRP. The ability of vasoactive intestinal polypeptide to increase left gastric arterial blood flow remained unaltered by L-NAME. 3. L-NAME (20 and 60 mumol kg-1, i.v.) evoked a prompt and sustained rise of mean arterial blood pressure (MAP) and caused a slight decrease in the hypotensive activity of CGRP. In contrast, D-NAME induced a delayed and moderate increase in MAP and did not influence the hypotensive activity of CGRP. 4. Rat CGRP-alpha dilated the isolated perfused bed of the rat LGA precontracted with methoxamine and was 3 times more potent in this respect than rat CGRP-beta. The dilator action of rat CGRP-alpha in this preparation was not affected by L-NAME or D-NAME (40 microM). 5. L-NAME (60 micromol kg-1, i.v.) reduced gastric mucosal blood flow as assessed by laser Doppler flowmetry and diminished the hyperaemic activity of rat CGRP-alpha in the gastric mucosa by a factor of 4.5, whereas D-NAME was without effect.6. These data show that CGRP is a potent dilator of mucosal and extramural resistance vessels in the rat stomach. Its dilator action involves both NO-dependent and NO-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220901      PMCID: PMC2175986          DOI: 10.1111/j.1476-5381.1993.tb13824.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A role for nitric oxide in capsaicin-induced gastroprotection.

Authors:  B M Peskar; M Respondek; K M Müller; B A Peskar
Journal:  Eur J Pharmacol       Date:  1991-05-30       Impact factor: 4.432

2.  Calcitonin gene-related peptide-containing neurons supplying the rat digestive system: differential distribution and expression pattern.

Authors:  C Sternini; K Anderson
Journal:  Somatosens Mot Res       Date:  1992       Impact factor: 1.111

3.  Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation.

Authors:  B L Tepperman; B J Whittle
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Role of calcitonin gene-related peptide in capsaicin-induced gastric submucosal arteriolar dilation.

Authors:  R Y Chen; D S Li; P H Guth
Journal:  Am J Physiol       Date:  1992-05

5.  Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion.

Authors:  J M Pique; J V Esplugues; B J Whittle
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

6.  Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion.

Authors:  I T Lippe; P Holzer
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

7.  Nitric oxide mediates rat mucosal vasodilatation induced by intragastric capsaicin.

Authors:  B J Whittle; J Lopez-Belmonte; S Moncada
Journal:  Eur J Pharmacol       Date:  1992-08-06       Impact factor: 4.432

8.  Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett; R Foulkes; B Hughes
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

9.  Mechanism of the vasodilator action of calcitonin gene-related peptide in conscious rats.

Authors:  A Abdelrahman; Y X Wang; S D Chang; C C Pang
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

View more
  16 in total

1.  Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.

Authors:  Katsushi Nishihara; Yoshihisa Nozawa; Motoko Nakano; Hirofusa Ajioka; Naosuke Matsuura
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  The effects of calcitonin gene-related peptide on tracheal smooth muscle of guinea-pigs in vitro.

Authors:  H Ninomiya; Y Uchida; T Endo; M Ohtsuka; A Nomura; M Saotome; S Hasegawa
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Pathway-specific effects of calcitonin gene-related peptide on irideal arterioles of the rat.

Authors:  C E Hill; D J Gould
Journal:  J Physiol       Date:  1997-12-15       Impact factor: 5.182

4.  Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats.

Authors:  Yasutada Akiba; Jonathan D Kaunitz; Mulugeta Million
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

5.  Role of endothelium and nitric oxide in modulating in vitro responses of colonic arterial and venous rings to vasodilatory neuropeptides in horses.

Authors:  Rustin M Moore; Steven A Sedrish; Earnestine P Holmes; Catherine E Koch; Changaram S Venugopal
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

6.  Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats.

Authors:  Atsufumi Kawabata; Yumiko Nakaya; Ryotaro Kuroda; Mariko Wakisaka; Takashi Masuko; Hiroyuki Nishikawa; Kenzo Kawai
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

7.  Visceral vasodilatation and somatic vasoconstriction evoked by acid challenge of the rat gastric mucosa: diversity of mechanisms.

Authors:  C Wachter; A Heinemann; M Jocic; P Holzer
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

Review 8.  Cholecystokinin-induced gastroprotection: a review of current protective mechanisms.

Authors:  Sonlee D West; David W Mercer
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

9.  Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa.

Authors:  G Pethö; M Jocic; P Holzer
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Cod CGRP and tachykinins in coeliac artery innervation of the Atlantic cod, Gadus morhua: presence and vasoactivity.

Authors:  Fatemeh Shahbazi; Susanne Holmgren; Jörgen Jensen
Journal:  Fish Physiol Biochem       Date:  2008-10-04       Impact factor: 2.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.